Literature DB >> 34220352

Bioaerosols from mouth-breathing: Under-recognized transmissible mode in COVID-19?

Saravanakarthikeyan Balasubramanian1, Divya Vinayachandran2.   

Abstract

The whole world has been affected by the coronavirus disease 2019 (COVID-19) pandemic, and many researchers are racing to understand the disease course and to undertake risk analyses to formulate effective treatment strategies. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly transmissible through coughing and sneezing, and through breathing and talking which may account for viral transmission from asymptomatic carriers. Bioaerosols produced during mouth-breathing, an expiratory process in habitual mouth breathers, should be considered in addition to nasal bioparticles as a potential transmissible mode in COVID-19. Oral health professionals are justifiably apprehensive about the exposure risk due to close face-to-face contact and the mode of transmission. The aim of this commentary is to summarize the research conducted in this area and suggested strategies to limit the spread of COVID-19, especially in dental offices.

Entities:  

Keywords:  COVID-19; Keywords: bioaerosols; coronavirus; mouth-breathing; oral diagnosis; transmission risk

Year:  2021        PMID: 34220352      PMCID: PMC8219058          DOI: 10.14745/ccdr.v47i56a05

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  13 in total

1.  Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee.

Authors:  J S Garner
Journal:  Infect Control Hosp Epidemiol       Date:  1996-01       Impact factor: 3.254

2.  Temporal dynamics in viral shedding and transmissibility of COVID-19.

Authors:  Xi He; Eric H Y Lau; Peng Wu; Xilong Deng; Jian Wang; Xinxin Hao; Yiu Chung Lau; Jessica Y Wong; Yujuan Guan; Xinghua Tan; Xiaoneng Mo; Yanqing Chen; Baolin Liao; Weilie Chen; Fengyu Hu; Qing Zhang; Mingqiu Zhong; Yanrong Wu; Lingzhai Zhao; Fuchun Zhang; Benjamin J Cowling; Fang Li; Gabriel M Leung
Journal:  Nat Med       Date:  2020-04-15       Impact factor: 53.440

3.  Presumed Asymptomatic Carrier Transmission of COVID-19.

Authors:  Yan Bai; Lingsheng Yao; Tao Wei; Fei Tian; Dong-Yan Jin; Lijuan Chen; Meiyun Wang
Journal:  JAMA       Date:  2020-04-14       Impact factor: 56.272

4.  Inhalatory infection of mice with influenza A0/PR8 virus. II. Detection of the virus in the blood and extrapulmonary organs.

Authors:  V Franková; V Rychterová
Journal:  Acta Virol       Date:  1975-01       Impact factor: 1.162

5.  Inhaling to mitigate exhaled bioaerosols.

Authors:  David A Edwards; Jonathan C Man; Peter Brand; Jeffrey P Katstra; K Sommerer; Howard A Stone; Edward Nardell; Gerhard Scheuch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

6.  [Nasal obstruction and mouth breathing: the ENT's point of view].

Authors:  Nicolas Leboulanger
Journal:  Orthod Fr       Date:  2013-05-30

7.  Etiology, clinical manifestations and concurrent findings in mouth-breathing children.

Authors:  Rubens Rafael Abreu; Regina Lunardi Rocha; Joel Alves Lamounier; Angela Francisca Marques Guerra
Journal:  J Pediatr (Rio J)       Date:  2008 Nov-Dec       Impact factor: 2.197

8.  Could nasal nitric oxide help to mitigate the severity of COVID-19?

Authors:  Jan Martel; Yun-Fei Ko; John D Young; David M Ojcius
Journal:  Microbes Infect       Date:  2020-05-06       Impact factor: 2.700

9.  The coronavirus pandemic and aerosols: Does COVID-19 transmit via expiratory particles?

Authors:  Sima Asadi; Nicole Bouvier; Anthony S Wexler; William D Ristenpart
Journal:  Aerosol Sci Technol       Date:  2020-04-03       Impact factor: 2.908

10.  Characterization of expiration air jets and droplet size distributions immediately at the mouth opening.

Authors:  C Y H Chao; M P Wan; L Morawska; G R Johnson; Z D Ristovski; M Hargreaves; K Mengersen; S Corbett; Y Li; X Xie; D Katoshevski
Journal:  J Aerosol Sci       Date:  2008-11-07       Impact factor: 3.433

View more
  1 in total

Review 1.  Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic.

Authors:  Nadezhda Ivanova; Yoana Sotirova; Georgi Gavrailov; Krastena Nikolova; Velichka Andonova
Journal:  Pharmaceutics       Date:  2022-02-27       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.